Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth L McClain

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Blood|March 31, 2018
Fire behind the fury: IL-18 and MASKenneth L McClain, Carl E Allen
Pediatric Blood & Cancer|December 8, 2005
A phase II trial using thalidomide for Langerhans cell histiocytosisKenneth L McClain, Claudia A Kozinetz
Blood|March 12, 2011
Erdheim-Chester: beyond the lesionCarl E Allen, Kenneth L McClain
Hematology. American Society of Hematology. Education Program|December 6, 2015
Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosisCarl E Allen, Kenneth L McClain
Nature Medicine|May 9, 2009
Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesionsCarl E Allen, Kenneth L McClain
Blood|August 23, 2014
fHLH: becoming a blended familyCarl E Allen, Kenneth L McClain
British Journal of Haematology|March 31, 2015
Treatment of Langerhans cell histiocytosis: it is time to learn from the past: response to Minkov and Rodriguez-GalindoCarl E Allen, Kenneth L McClain
Pediatrics|May 3, 2003
Hemophagocytic lymphohistiocytosis masquerading as child abuse: presentation of three cases and review of central nervous system findings in hemophagocytic lymphohistiocytosisLaura Rooms, Nancy Fitzgerald, Kenneth L McClain
Blood|March 13, 2020
Checkmate for EBV-HLHNader Kim El-Mallawany, Kenneth L McClain
Blood|April 2, 2015
How I treat Langerhans cell histiocytosisCarl E Allen, Stephan Ladisch, Kenneth L McClain
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Blood|March 31, 2018
Fire behind the fury: IL-18 and MASKenneth L McClain, Carl E Allen
Pediatric Blood & Cancer|December 8, 2005
A phase II trial using thalidomide for Langerhans cell histiocytosisKenneth L McClain, Claudia A Kozinetz
Blood|March 12, 2011
Erdheim-Chester: beyond the lesionCarl E Allen, Kenneth L McClain
Hematology. American Society of Hematology. Education Program|December 6, 2015
Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosisCarl E Allen, Kenneth L McClain
Nature Medicine|May 9, 2009
Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesionsCarl E Allen, Kenneth L McClain
Blood|August 23, 2014
fHLH: becoming a blended familyCarl E Allen, Kenneth L McClain
British Journal of Haematology|March 31, 2015
Treatment of Langerhans cell histiocytosis: it is time to learn from the past: response to Minkov and Rodriguez-GalindoCarl E Allen, Kenneth L McClain
Pediatrics|May 3, 2003
Hemophagocytic lymphohistiocytosis masquerading as child abuse: presentation of three cases and review of central nervous system findings in hemophagocytic lymphohistiocytosisLaura Rooms, Nancy Fitzgerald, Kenneth L McClain
Blood|March 13, 2020
Checkmate for EBV-HLHNader Kim El-Mallawany, Kenneth L McClain
Blood|April 2, 2015
How I treat Langerhans cell histiocytosisCarl E Allen, Stephan Ladisch, Kenneth L McClain
Pageof 12